Open Access

Screening of recombinant proteins as antigens in indirect ELISA for diagnosis of bovine tuberculosis

  • Ingrid IF Souza1,
  • Elaine SP Melo1,
  • Carlos AN Ramos2Email author,
  • Thaís A Farias1,
  • Ana Luiza AR Osório1,
  • Klaudia SG Jorge1,
  • Carlos ES Vidal3,
  • Altino S Silva4,
  • Márcio R Silva5,
  • Aiesca O Pellegrin6 and
  • Flábio R Araújo7
SpringerPlus20121:77

DOI: 10.1186/2193-1801-1-77

Received: 21 September 2012

Accepted: 17 December 2012

Published: 22 December 2012

Abstract

Bovine tuberculosis is an important infectious disease caused by Mycobacterium bovis, which is responsible for considerable economic losses. This disease constitutes a serious public health problem. Control programs in most countries, including Brazil, are based on the identification and slaughter of infected animals, as defined by the skin tuberculin test, which has its constraints. In the present study, the recombinant proteins CFP-10, ESAT-6, Mb0143, MPB83, PE5, PE13, TB10.4, TB15.3 and a chimera of ESAT-6/MPB70/MPB83 (fusion protein) were tested as ELISA antigens for the diagnosis of bovine tuberculosis. The proteins were produced in Escherichia coli, purified and tested in ELISAs with sera from 126 cattle having tested negative in the comparative intradermal tuberculin test (CITT) and 107 sera from cattle having tested positive in the CITT. Also, 236 sera from two BTB-free beef cattle herds were tested. Among the proteins tested, only the ESAT-6/MPB70/MPB83 chimera demonstrated satisfactory agreement with the CITT (kappa index: 0.688), reflecting in 83.2% sensitivity and 86.5% specificity. The ELISA absorbances of the cattle sera from BTB-free herds showed similar levels to those of CITT positive cattle, probably as the result of successive skin tuberculinizations to define the BTB-free status of the herds. However, the ELISA with the ESAT-6/MPB70/MPB83 chimera was useful to discriminate BTB positive and negative cattle in herds prior to the tuberculin skin test.

Keywords

Serology ELISA Recombinant proteins Mycobacterium bovis Cattle

Background

Bovine tuberculosis is a chronic infectious disease caused by Mycobacterium bovis, which affects cattle (Wobeser 2009), other domesticated species, wild animals and humans (Gutierrez et al. 1998; Michel et al. 2011). This disease causes economic losses in livestock farming and poses a health risk to the population that consumes products of animal origin (Lilebaum et al. 2001; Bennett and Cooke 2006).

The detection of tuberculosis in cattle is based mainly on the measurement of delayed hypersensitivity following the intradermal injection of M. bovis antigens, which are usually purified protein derivatives (Whelan et al. 2011). Despite the effectiveness of diagnostic approaches based on the detection of the cellular immune response to M. bovis antigens, skin tests must be conducted in vivo, which is difficult in large-scale epidemiological surveys and retrospective epidemiological analyses (Menzies 1999; Liu et al. 2007). Moreover, a number of chronically infected animals may go undetected even after skin and IFN-γ tests, which places herds at risk for the bovine-to-bovine spread of infection.

Antibody responses to M. bovis are positively correlated with the mycobacterial-elicited pathology and antigen burden. Thus, serological tests may increase the degree of detection of animals infected with M. bovis (Whelan et al. 2011). Serological tests may also constitute an alternative for screening herds for M. bovis infection as well as retrospectively testing sera from control programs for other diseases, such as bovine brucellosis.

A limited number of antigens have been tested in immunoassays for the diagnosis of bovine tuberculosis. Antigens such as ESAT-6, MPB70 and MPB83 have been extensively evaluated in enzyme-linked immunosorbent assay (ELISA) (Buddle et al. 1995; Amadori et al. 2002; Farias et al. 2012), however, its sensitivity and specificity are relatively low. Thus, the search for new antigens for serological diagnosis of bovine tuberculosis is required.

The aim of the present study was to test the recombinant proteins CFP-10, ESAT-6, Mb0143, MPB83, PE5, PE13, TB10.4, TB15.3 and a chimera of ESAT-6/MPB70/MP83 peptides as ELISA antigens for the diagnosis of bovine tuberculosis. CFP-10, ESAT-6 and MPB83, as a chimera of ESAT-6/MPB70/MP83 have been previously tested as an antigen (Amadori et al. 2002; Liu et al. 2007), however, Mb0143, PE5, PE13, TB10.4 and TB15.3 are being evaluated for the first time. The selection of these proteins was based on the localization of the protein in cell wall of the Mycobacerium bovis, such as PE5 and PE13 (Garnier et al. 2003; Aagaard et al. 2006), or because they are secreted proteins as TB10.4 and TB15.3 (Mattow et al. 2003). Mb0143 is a conserved hypothetical protein and has been evaluated in IFN-γ assay (Meikle et al. 2009).

Results

Production of recombinant proteins

The fragments corresponding to the coding regions of genes cfp-10, esat-6, mb0143, mpb83, pe5, pe13, tb10.4, and tb15.3 were amplified by PCR, generating amplicons of 300, 288, 459, 604, 270, 219, 231 and 408 base pairs, respectively.

Gene expressions were determined through electrophoresis in SDS-PAGE, which revealed the recombinant proteins CFP-10, chimera of ESAT-6/MPB70/MPB83, ESAT-6, MPB83, MB0143, PE5, PE13, TB10.4 and TB15.3 to have 13.6, 35, 12.9, 20.5, 28.5, 17.5, 12.5, 11.6 and 17.5 KDa, respectively. These findings are consistent with the in silico predicted molecular masses analyzed using the EdiSeq of the DNASTAR program, indicating that the proteins were not post-translationally modified. In Western blotting, all recombinant proteins were recognized by the anti-6x-histidine antibody, thereby confirming gene expression.

ELISAs

Table 1 displays the optimal dilutions of sera and antigen concentrations. To evaluate the accuracy of the ELISAs, serum samples were obtained from cattle tested positive in the CITT and from cattle tested negative in the CITT from different states of Brazil. The technicians were blinded to the sample sets being tested and corresponding skin test status.
Table 1

Optimal dilutions of sera and recombinant proteins of Mycobacterium bovis for ELISA

ELISA

Optimal dilutions

Serum

Recombinant proteins (final concentration μg/ml)

CFP-10

1: 600

1: 10,000 (0.1)

Chimera *

1: 600

1: 5000 (0.2)

ESAT-6

1: 600

1: 5000 (0.2)

Mb0143

1: 600

1: 10,000 (0.1)

MPB83

1: 600

1: 10,000 (0.1)

PE13

1: 600

1: 500 (2.0)

PE5

1: 400

1: 500 (2.0)

TB10.4

1: 400

1: 2000 (0.5)

TB15.3

1: 400

1: 5000 (0.2)

* Chimera – fusion of MPB70, MPB83 and ESAT-6 fragments.

Figure 1 displays the normalized ELISA absorbances. Results are expressed as relative sensitivity or relative specificity taking CITT as the reference test. Relative sensitivity ranged from 28.0% to 83.2% and relative specificity ranged from 58.7% to 92.9%. The highest relative specificity (92.9%) of the ELISA with CFP-10 was in detriment to the relative sensitivity of the test (28.0%).
Figure 1

Distributions of normalized absorbances of ELISAs with recombinant proteins of Mycobacterium bovis.

Regarding the kappa test, only ELISA with the chimera of the ESAT-6/MPB70/MPB83 peptides demonstrated adequate agreement with the CITT (kappa index: 0.688; confidence interval: 0.595-0.782). ELISAs with ESAT-6, MPB83 and PE5 exhibited fair agreement with the CITT (kappa index: 0.447, 0.554 and 0.404, respectively) and the other ELISAs exhibited minimal agreement with the CITT (kappa index: < 0.4).

The normalized ELISA absorbances of the cattle sera from BTB-free herds showed similar levels to those of CITT positive cattle (Figure 2).
Figure 2

Dot-plot showing normalized ELISA absorbance of sera from CITT negative, CITT positive cattle, BTB-free beef cattle and dairy cattle herds. The chimera antigen (MPB70/MPB83/ESAT-6) alone was used as a model in this figure, as it provided better differentiation between positive or negative cattle for tuberculosis.

Discussion

The performance of the ELISA with the ESAT-6/MPB70/MPB83 chimera was superior to that of ESAT-6 or MPB83 individually. It was not possible to analyze MPB70 individually as an antigen due to problems with the purification of the recombinant protein.

The kinetics of the antibody responses to different M. bovis antigens is variable upon infection. Anti-MPB83 antibodies can be detected relatively early, typically around four weeks post-infection (Waters et al. 2006). Anti-ESAT-6 antibodies can be detected 12 weeks after experimental infection (Lyashchenko et al. 1998). In contrast, antibodies for MBP70 usually develop 18 to 22 months after experimental infection (Harboe et al. 1990; Fifis et al. 1992). Thus, chimeras containing important epitopes of major proteins of M. bovis are expected to be able to detect antibodies from cattle in different stages of infection, thereby increasing the diagnostic coverage. Similar results are reported in a chemiluminescent assay with multiple antigens, in which sensitivity and specificity were superior to those of individual antigens, including ESAT-6 and MPB83 (Whelan et al. 2008). The choice for the production of a chimera of antigens instead of a cocktail of individual antigens is justified by the facility of a single expression and protein purification, with lower costs and no issues regarding the ratio of various antigens.

The cutoff values in this study were determined using ROC analysis, resulting, in the case of ELISA with the ESAT-6/MPB70/MPB83 chimera, in a relative sensitivity of 83.2% and an a relative specificity of 86.5%, taking CITT as the reference test. If we take a practical relative specificity of 95%, the relative sensitivity would be 67.3%, which is similar to those found with another chimera using the same antigens (69.4% sensitivity and 96% specificity) reported in a previous study (Liu et al. 2007). ELISA with a blend of MPB70 and MPB83 has also demonstrated good results (63% sensitivity and 98% specificity) (Waters et al. 2011). These findings strongly support the use of multiple antigens for the detection of cattle infected with M. bovis.

Besides the antigens that are traditionally used for serology (ESAT-6, MPB70 and MPB83), others that have demonstrated promising results in cellular assays were tested for serology, such as CFP-10, Mb0143, PE13, TB10.4 and TB15.3 (Aagaard et al. 2003; Aagaard et al. 2006). Among these antigens, only ELISA with PE5 demonstrated fair agreement with the CITT. Our group also found promising results with PE5 in intradermal tests with cattle experimentally immunized with the inactivated AN5 strain of M. bovis (data not shown). The potential of this antigen in chimera constructs will be evaluated in future studies using ELISA for M. bovis antibodies.

The similar responses of two BTB-free herds and CITT positive cattle suggest that the repeated tuberculin test, which is necessary for the establishment of the BTB-free status of the herd, may act as a booster to antibody production, as described in other studies for BTB (Harboe et al. 1990, Monaghan et al. 1994) and for bovine paratuberculosis (Varges et al. 2009). Other possibility is the sensitization of the BTB-free animals with environmental mycobacteria, and cross-reactions with the antigens, but with the herd of Embrapa Beef Cattle, which was tested with tuberculin only on the same day that serum samples were obtained, the discrimination was clearly higher. For this reason, ELISA is a useful tool for the identification of BTB positive herds prior to the tuberculin skin test.

As in many countries, the diagnosis of bovine tuberculosis in Brazil is based on routine testing with the intradermal tuberculin test. Skin tests require containment of the animals on two occasions with a 72-h interval for measuring the thickness of the skin fold (Brasil 2004). Management is hampered in herds raised extensively or on farms without adequate facilities, which is a common situation in developing countries. This difficulty is probably one of the main reasons for why epidemiological surveys of tuberculosis planned in the eradication program in Brazil are in a less advanced stage than those for brucellosis.

An ancillary antibody-based assay, such as ELISA with the ESAT-6/MPB70/MPB83 chimera, offers the possibility of identifying BTB positive herds using sera collected for other epidemiological studies, such as for brucellosis, prior to tuberculin skin tests, thereby increasing the diagnostic coverage. This is another useful aspect in the possible identification of cattle in advanced stages of tuberculosis with false-negative results on the skin test due to anergy (Whelan et al. 2011).

Materials and methods

Antigens

Mycobacterium bovis DNA (AN5 strain) was purified from Stonebrink’s medium cultures using a commercial kit (DNeasy Blood & Tissue kit, Qiagen). The primers were designed with the PrimerSelect program (DNAStar) to amplify the cfp-10, esat-6, mb0143, mpb83, pe5, tb10.4 and tb15.3 genes (Table 2). Polymerase chain reactions (PCR) were carried out in a volume of 25 μl, containing 20 mM of Tris, pH 8.4, 50 mM of KCl, 1.5 mM of MgCl2, 250 μM of each dNTP, 100 ηg of each primer, 0.2 U of Taq DNA polymerase (Invitrogen) and a 50 ηg of M. bovis DNA. The amplification protocols were performed based on the characteristics of each pair of primers.
Table 2

Primers for amplification of gene fragments coding for Mycobactyerium bovis antigens

Gene

DNA sequence

cfp-10

5’ GCAGACATGAAGACCGATGCCGCTACC 3’

5’ TCACAAGCCCATTTGCGAGGACAGC 3’

esat-6

5’ ATGACAGAGCAGCAGTGGAATTTC 3’

5’ CTATGCGAACATCCCAGTGAC 3’

mb0143

5’ GCTTCGGAGTTCTCCCGTGCTGAA 3’

5’ CTCGTCGAGGGTGCCCAACTCCT 3’

mpb83

5’ ATGATCAACGTTCAGGCCA 3’

3’ GAACTCCGCCACATACCAAA 3’

pe13

5’ TCTTTCGTGATGGCATACCC 3’

5’ GACTTCAGTGGCCGAA 3’

pe5

5’ ATGACGTTGCGAGTGGTTC 3’

5’ TCAGCCGCCCACGAC 3’

tb10.4

5’ ATGTACAACTACCCCGCGAT 3’

5’ CATGGTGTTGGCTTCATGG 3’

tb15.3

5’ AGCGCCTATAAGACCGTGGTGGTA 3’

5’ CTTGGCCCGGCGTGACACATTGG 3’

Following amplification, the genes were initially cloned in pGEM-T Easy (Promega) plasmid, following the manufacturer’s instructions. Cloned genes were sequenced in both directions using the BigDye Terminator v.3.1 kit (Applied Biosystems). After digestion with Eco RI, the genes were subcloned in pET47-b (Novagen), except tb10.4, which was cloned in pET28-a (Novagen), and mpb83, which was cloned in pRSET-C (Invitrogen).

An 846-nucleotide synthetic chimera was constructed (Genone) with DNA coding sequences for the hydrophilic domains of ESAT-6, MPB70 and MPB83 and cloned in the Eco RI site of pET47-b. This chimera was constructed with nucleotides 18693–19025 of mpb70 (BX248344.1, fragment 11/14), 15664–15966 of mpb83 (BX248344.1, fragment 11/14) and 221989–222198 of esat-6 (BX248341.1, fragment 14/14).

The Escherichia coli Rosetta strain was used as the host cells for all DNA constructs. The induction of gene expression was performed using 1 mM of IPTG in 500 ml of LB broth with 50 μg/ml of chloramphenicol and 30 μg/ml of kanamycin for pET47-b and pET28-a or 50 μg/ml of chloramphenicol and 100 μg/ml of ampicillin for pRSET-C at 37°C for 4 h at 250 rpm. Gene expression was confirmed using SDS-PAGE and Western blotting with the anti-6x-histidine monoclonal antibody (Sigma).

Recombinant proteins were solubilized with 6 M of HCl-guanidine and purified using the His-Trap HP agarose-nickel resin (GE Healthcare), following the manufacturer’s instructions. Recombinant proteins were dialyzed with PBS at 4°C for 48 h and concentrations were determined by comparisons with known concentrations of bovine serum albumin in SDS-polyacrylamide gel (SDS-PAGE), using the LabImage v.3.3.2 program (Loccus).

As the proteins became insoluble after dialysis, solubilization with 2% SDS was conducted as described elsewhere (Lechtzier et al. 2002).

Evaluation of ELISAs

Optimal dilutions of recombinant proteins, sera and conjugate were determined through the analysis of four sera from cattle having tested positive in the comparative intradermal tuberculin test (CITT) and four sera from cattle having tested negative in the CITT (Table 1). The CITT was carried out and interpreted according to the technical regulation of the National Program of Control and Eradication of Brucellosis and Tuberculosis of the Brazilian Ministry of Agriculture (Brasil 2004).

Sera from 107 cattle having tested positive in the CITT from Caarapó, state of Mato Grosso do Sul, Itapemirim, state of Espírito Santo and Toropi, Tapera, São Martinho da Serra and Santa Maria, state of Rio Grande do Sul, Brazil, were evaluated in the ELISAs. Sera were obtained in non-specific time-point post skin tests.

Sera from 126 cattle having tested negative in the CITT from Campo Grande, state of Mato Grosso do Sul, Brazil, were also tested in the ELISAs. The CITT negative animals were from a herd with no history of bovine tuberculosis (BTB) of Embrapa Beef Cattle. Cattle from this research center are often slaughtered in official abattoirs, and there were no reports of BTB positive animals. Blood was collected for sera on the same day that the CIIT was carried out, to avoid interference from the tuberculin test on the immune status of the animals.

Among 126 animals having tested negative in the CITT, 51 (40.5%) were slaughtered and no lesions suggestive of BTB were found during meat inspection at an official slaughterhouse. All CITT positive animals were from herds with outbreaks of BTB, as evidenced by the presence of suggestive lesions during slaughter, the growth of acid-fast bacilli and PCR with primers for the M. tuberculosis complex (Rodriguez et al. 1995).

Moreover, 154 sera from a BTB-free beef cattle herd and 82 sera from a BTB-free dairy cattle herd were tested. The BTB-free status of the herds was established based on CITT, in compliance with the technical norms of the National Program for the Control and Eradication of Brucellosis and Tuberculosis of the Brazilian Ministry of Agriculture. Briefly, a herd is considered free of BTB after three consecutive negative tuberculin tests, with an interval of 90–120 days between the first and second tests, and an interval of 180–240 days between the second and third test (Brasil 2004).

Costar 3590 polystyrene 96-well plates (Corning) were adsorbed with each antigen in carbonate-bicarbonate buffer, pH 9.6, for 60 min at 37°C. The plates were then blocked with 100 μl/well of phosphate buffer saline with 0.1% Tween 20 (PBST) with 5% skim milk for 60 min at 37°C. After five washes with PBST, 100 μl/well of the control and test sera diluted in PBST with 2% skim milk were incubated for 60 min at 37°C. The plates were washed five times with PBST. Next, 100 μl of monoclonal antibody anti-bovine IgG (heavy chain) horseradish peroxidase conjugate (Sigma, A5295) (dilution: 1:10,000 in PBST) were added to each well. The plates were incubated for 30 min at 37°C, washed five times and 50 μl/well of chromogen/substrate Fast OPD (Sigma, P9187) were added to each well. The reactions were stopped with 2.5 N of H2SO4 and the results were read on an EL-800 ELISA reader (Bio-Tek) with a 490 ηm filter.

To minimize the effect of intra-assay and inter-assay variations, ELISA absorbances were normalized based on the methodology described by Ramanakumar et al. (2010).

Statistical analysis

ELISA cutoff points were determined by Receiver Operating Characteristic analysis (Metz 1978; Zweig and Campbell 1993), using the MEDCALC .10.3.0.0 software program. Agreement between CITT and ELIZA was assessed by kappa index according to Ansari-Lari (2005).

Purpose of the work

We wanted to develop an ancillary diagnostic test to bovine tuberculosis, based on ELISA with recombinant proteins.

Declarations

Acknowledgments

This study was funded by the Brazilian agencies CNPq (505837/2008-0) and Embrapa (0208060040000).

Authors’ Affiliations

(1)
Pós Graduação em Ciência Animal, Universidade Federal de Mato Grosso do Sul
(2)
DTI CNPq grant holder, Embrapa Gado de Corte
(3)
Pós Graduação em Medicina Veterinária, Universidade Federal de Santa Maria
(4)
Instituto de Defesa Agropecuária e Florestal do Espírito Santo
(5)
Embrapa Gado de Leite
(6)
Embrapa Pantanal
(7)
Embrapa Gado de Corte

References

  1. Aagaard C, Govaerts M, Meikle V, Vallecillo AJ, Gutierrez-Pabello JA, Suarez-Güemes F, McNair J, Cataldi A, Espitia C, Andersen P, Pollock JM: Optimizing antigen cocktails for detection of Mycobacterium bovis in herds with different prevalences of bovine tuberculosis: ESAT6-CFP10 mixture shows optimal sensitivity and specificity. J Clin Microbiol 2006, 44: 4326-4335. 10.1128/JCM.01184-06View ArticleGoogle Scholar
  2. Aagaard C, Govaerts M, Meng OL, Andersen P, Pollock JM: Genomic approach to identification of Mycobacterium bovis diagnostic antigens in cattle. J Clin Microbiol 2003, 8: 3719-3728.View ArticleGoogle Scholar
  3. Amadori M, Lyashchenko KP, Gennaro ML, Pollock JM, Zerbini I: Use of recombinant proteins in antibody tests for bovine tuberculosis. Vet Microbiol 2002, 85: 379-389. 10.1016/S0378-1135(02)00005-6View ArticleGoogle Scholar
  4. Ansari-Lari M: Comparison between two tests results, kappa statistic instead of simple overall agreement. Vet Parasitol 2005, 133: 369-370. 10.1016/j.vetpar.2005.06.005View ArticleGoogle Scholar
  5. Bennett RM, Cooke RJ: Costs to farmers of a tuberculosis breakdown. Vet Rec 2006, 158: 429-432. 10.1136/vr.158.13.429View ArticleGoogle Scholar
  6. Brasil: Secretaria de Defesa Agropecuária, Ministério da Agricultura, Pecuária e Abastecimento. Instrução Normativa Nº 6 de 8 de janeiro de 2004. Aprova o Regulamento Técnico do Programa Nacional de Controle e Erradicação da Brucelose e Tuberculose Animal. Diário Oficial da União, Brasília; 2004:6-10.Google Scholar
  7. Buddle BM, Nolan A, McCarthy AR, Heslop J, Aldwell FE, Jackson R: Evaluation of three serological assays for the diagnosis of Mycobacterium bovis infection in brushtail possums. N Z Vet J 1995, 43: 91-95. 10.1080/00480169.1995.35860View ArticleGoogle Scholar
  8. Farias TA, Araújo FR, Osório SLAR, Jorge KSG, Ramos CAN, Souza IIF, Azambuja A, Soares CO, Silva MR, Pellegrin AO: ELISA based on recombinant MPB70 and P27 for detection of antibodies against Mycobacterium bovis. Revista de Patologia Tropical 2012, 41: 155-162.View ArticleGoogle Scholar
  9. Fifis T, Costopoulos C, Corner LA, Wood PR: Serological reactivity to Mycobacterium bovis protein antigens in cattle. Vet Microbiol 1992, 30: 343-354. 10.1016/0378-1135(92)90021-KView ArticleGoogle Scholar
  10. Garnier T, Eiglmeier K, Camus JC, Medina N, Mansoor H, Pryor M, Duthoy S, Lacroix C, Monsempe C, Simon S, Harris B, Atkin R, Doggett J, Mayes R, Keating L, Wheeler PR, Parkhill J, Barrell BG, Cole ST, Gordon SV, Hewinson RG: The complete genome sequence of Mycobacterium bovis. Microbiology 2003, 100: 7877-7882.Google Scholar
  11. Gutierrez M, Tellechea J, Garcia Marin JF: Evaluation of cellular and serological diagnostic tests for the detection of Mycobacterium bovis-infected goats. Vet Microbiol 1998, 62: 281-290. 10.1016/S0378-1135(98)00217-XView ArticleGoogle Scholar
  12. Harboe M, Wiker HG, Duncan JR, Garcia MM, Dukes TW, Brooks BW, Turcotte C, Nagai S: Protein G-based enzyme-linked mmunosorbent assay for anti-MPB70 antibodies in bovine tuberculosis. J Clin Microbiol 1990, 28: 913-921.Google Scholar
  13. Lechtzier V, Hutoran M, Levy T, Kotler M, Brenner T, Steinitz M: Sodium dodecyl sulphate-treated proteins as ligands in ELISA. J Immunol Methods 2002, 270: 19-26. 10.1016/S0022-1759(02)00214-4View ArticleGoogle Scholar
  14. Lilebaum W, Pessolani MCV, Fonseca LSF: The use of Ag85 complex as antigen in elisa for the diagnosis of bovine tuberculosis in dairy cows in Brazil. Journal of Veterinary Medicine 2001, 48: 161-166. 10.1046/j.1439-0450.2001.00437.xView ArticleGoogle Scholar
  15. Liu S, Guo S, Wang C, Shao M, Zhang X, Guo Y, Gong Q: A novel fusion protein-based indirect enzyme-linked immunosorbent assay for the detection of bovine tuberculosis. Tuberculosis 2007, 87: 212-217. 10.1016/j.tube.2006.07.007View ArticleGoogle Scholar
  16. Lyashchenko KP, Pollock JM, Colangeli R, Gennaro ML: Diversity of antigen recognition by serum antibodies in experimental bovine tuberculosis. Infect Immun 1998, 66: 5344-5449.Google Scholar
  17. Mattow J, Schaible UE, Schmidt F, Hagens K, Siejak F, Brestrich G, Haeselbarth G, Müller EC, Jungblut PR, Kaufmann SH: Comparative proteome analysis of culture supernatant proteins from virulent Mycobacterium tuberculosis H37Rv and attenuated M. bovis BCG Copenhagen. Electrophoresis 2003, 24: 3405-3420. 10.1002/elps.200305601View ArticleGoogle Scholar
  18. Meikle V, Alito A, Llera AS, Gioffré A, Peralta A, Buddle BM, Cataldi A: Identification of novel Mycobacterium bovis antigens by dissection of crude protein fractions. Clin Vaccine Immunol 2009, 16: 1352-1359. 10.1128/CVI.00211-09View ArticleGoogle Scholar
  19. Menzies D: Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 1999, 159: 15-21.View ArticleGoogle Scholar
  20. Metz CE: Basic principles of ROC analysis. Semin Nucl Med 1978, 8: 283-298. 10.1016/S0001-2998(78)80014-2View ArticleGoogle Scholar
  21. Michel AL, Cooper D, Jooste J, de Klerk LM, Jolles A: Approaches towards optimising the gamma interferon assay for diagnosing Mycobacterium bovis infection in African buffalo (Syncerus caffer). Prev Vet Med 2011, 98: 142-151. 10.1016/j.prevetmed.2010.10.016View ArticleGoogle Scholar
  22. Monaghan ML, Doherty ML, Collins JD, Kazda JF, Quinn PJ: The tuberculin test. Vet Microbiol 1994, 40: 111-124. 10.1016/0378-1135(94)90050-7View ArticleGoogle Scholar
  23. Ramanakumar AV, Thomann P, Candeias JM, Ferreira S, Villa LL, Franco EL: Use of the normalized absorbance ratio as an internal standardization approach to minimize measurement error in enzyme-linked immunosorbent assays for diagnosis of human papillomavirus infection. J Clin Microbiol 2010, 48: 791-796. 10.1128/JCM.00844-09View ArticleGoogle Scholar
  24. Rodriguez JG, Mejia GA, Dell PP, Patarroyo ME, Murillo LA: Species-specific identification of Mycobacterium bovis by PCR. Microbiology 1995, 141: 2131-2138. 10.1099/13500872-141-9-2131View ArticleGoogle Scholar
  25. Varges R, Marassi CD, Oelemann W, Lilenbaum W: Interference of intradermal tuberculin tests on the serodiagnosis of paratuberculosis in cattle. Res Vet Sci 2009, 86: 371-372. 10.1016/j.rvsc.2008.08.006View ArticleGoogle Scholar
  26. Waters WR, Buddle BM, Vordermeier HM, Gormley E, Palmer MV, Thacker TC, Bannantine JP, Stabel JR, Linscott R, Martel E, Milian F, Foshaug W, Lawrence JC: Development and evaluation of an enzyme-linked immunosorbent assay for use in the detection of bovine tuberculosis in cattle. Clin Vaccine Immunol 2011, 18: 1882-1888. 10.1128/CVI.05343-11View ArticleGoogle Scholar
  27. Waters WR, Palmer MV, Thacker TC, Bannantine JP, Vordermeier HM, Hewinson RG, Greenwald R, Esfandiari J, McNair J, Pollock JM, Andersen P, Lyashchenko KP: Early antibody responses to experimental Mycobacterium bovis infection of cattle. Clin Vaccine Immunol 2006, 13: 648-654. 10.1128/CVI.00061-06View ArticleGoogle Scholar
  28. Whelan C, Shuralev E, Kwok HF, Kenny K, Duignan A, Good M, Davis WC, Clarke J: Use of a multiplex enzyme-linked immunosorbent assay to detect a subpopulation of Mycobacterium bovis-infected animals deemed negative or inconclusive by the single intradermal comparative tuberculin skin test. J Vet Diagn Invest 2011, 23: 499-503. 10.1177/1040638711403410View ArticleGoogle Scholar
  29. Whelan C, Shuralev E, O'Keeffe G, Hyland P, Kwok HF, Snoddy P, O'Brien A, Connolly M, Quinn P, Groll M, Watterson T, Call S, Kenny K, Duignan A, Hamilton MJ, Buddle BM, Johnston JA, Davis WC, Olwill SA, Clarke J: Multiplex immunoassay for serological diagnosis of Mycobacterium bovis infection in cattle. Clin Vaccine Immunol 2008, 15: 1834-1838. 10.1128/CVI.00238-08View ArticleGoogle Scholar
  30. Wobeser C: Bovine tuberculosis in Canadian wildlife: An updated history. Can J Vet Res 2009, 50: 1169-1176.Google Scholar
  31. Zweig MH, Campbell G: Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993, 39: 561-577.Google Scholar

Copyright

© Souza et al.; licensee Springer. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.